Xi Jinping and George Freeman were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Jinping and Freeman were featured in the government and policy section, as LSIPR reports.
Names: Xi Jinping and George Freeman
Organisations: Chinese government and UK government
Positions: President of China and UK minister for life sciences
Xi Jinping was elected to the post of general secretary of the Communist Party in 2012 and president of China in 2013. During his visit to London in 2015, Jinping signed a £2 billion ($2.8 billion) deal with the UK minister for life sciences George Freeman. Under the collaboration, Chinese and UK companies will work together to further “research, hospital construction, training, diagnostics and drug discovery” in both countries.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Xi Jinping, George Freeman, Communist Party, life sciences, NHS, healthcare,